QA: Kura Oncology Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2021_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001422143, Kura Oncology Inc

  xvar xval
0 AssetsCurrent 637,292,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,021,000
3 remainder_Assets 7,899,000
4 LiabilitiesCurrent 26,024,000
5 LiabilitiesNoncurrent 10,283,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 48,059,408
9 ResearchAndDevelopmentExpense 64,873,861
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,541,676
13 remainder_ComprehensiveNetIncome 461,008
  yvar yval
0 Assets 647,212,000
1 Liabilities 36,307,000
2 Expenses 112,933,269
3 Revenues 0
4 StockholdersEquity 610,905,000
5 NetIncome -110,391,593
6 ComprehensiveNetIncome -110,161,089
7 BaseVar 399,727,476
8 EconomicCapitalRatiobeforeLimitedLiability 3.57
9 EconomicCapitalRatio 4.08

Edgar->Model Mapping

Feature Distribution

Change over Time